智慧氣喘監測設備市場規模、佔有率和成長分析：按產品、最終用途、地區分類 - 2025-2032 年產業預測

2023年全球智慧氣喘監測設備市場規模將為6.4596億美元，預測期內（2025-2032年）複合年成長率為25.6%，從2024年的8.1133億美元增至2032年的50.2473億美元。成長至 10,000,000 美元。

由於空氣污染加劇、易受室內空氣污染物影響的人數增加以及慢性阻塞性肺病和氣喘率顯著增加，智慧氣喘監測設備的全球市場正在顯著成長。推動這項擴張的關鍵因素包括智慧吸入器依從性的提高、向以患者為中心的護理的轉變以及製藥公司和智慧吸入器製造商之間的合作。先進的數位設備現在可以提醒用戶潛在的氣喘發作，有效監測依從性，促進資料傳輸到個人設備，並密切記錄用藥時間。行動醫療應用、穿戴式裝置和個人監測技術的整合在改善氣喘管理方面具有巨大潛力，將這些創新定位為持續對抗呼吸系統疾病的關鍵要素。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制因素和挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024）
• PESTEL分析
• 宏觀經濟指標
• 價值鏈分析
• 價格分析
• 監管環境
• 案例研究
• 技術進步
• 貿易分析

智慧氣喘監測設備市場規模：依產品分類

• 市場概況
• 穿戴式氣喘監測設備
• 智慧吸入器
• 吸入器
• 乾粉吸入器 (DPI)
• 定量噴霧吸入器(MDI)
• 噴霧器

按最終用途分類的智慧氣喘監測設備市場規模

• 市場概況
• 醫院
• 診所
• 家庭使用
• 其他

智慧氣喘監測設備市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2022-2024）

主要企業簡介

• Adherium Limited（New Zealand）
• AstraZeneca plc（United Kingdom）
• Boehringer Ingelheim International GmbH（Germany）
• Cohero Health, Inc.（United States）
• GlaxoSmithKline plc（United Kingdom）
• Health Care Originals, Inc.（United States）
• Koninklijke Philips NV（Netherlands）
• Teva Pharmaceutical Industries Ltd.（Israel）
• Vectura Group plc（United Kingdom）
• Volansys Technologies Pvt. Ltd.（India）
• 3M（United States）
• AEvice Health（Singapore）
• Respiri Limited（Australia）
• Quvium（United States）
• Findair（Poland）
• Sensirion AG（Switzerland）
• Thorasys Thoracic Medical Systems Inc.（Canada）
• Vitalograph Ltd.（Ireland）
• Zephyr Sleep Technologies（Canada）

結論和建議

Global Intelligent Asthma Monitoring Devices Market size was valued at USD 645.96 million in 2023 and is poised to grow from USD 811.33 million in 2024 to USD 5024.73 million by 2032, growing at a CAGR of 25.6% during the forecast period (2025-2032).

The global market for intelligent asthma monitoring devices is experiencing significant growth due to rising air pollution, an increase in individuals vulnerable to indoor air contaminants, and a notable upsurge in COPD and asthma cases. Key factors driving this expansion include enhanced adherence to smart inhalers, a shift towards patient-centered care, and partnerships between pharmaceutical firms and smart inhaler producers. Advanced digital devices now alert users to potential asthma attacks, effectively monitor adherence, and facilitate the transmission of data to personal devices, meticulously documenting dosing times. The integration of mobile health applications, wearables, and personal monitoring technologies holds tremendous potential for improving asthma management, positioning these innovations as critical components in the ongoing battle against respiratory conditions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Intelligent Asthma Monitoring Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Intelligent Asthma Monitoring Devices Market Segmental Analysis

Global Intelligent Asthma Monitoring Devices Market is segmented by product, end use and region. Based on product, the market is segmented into wearable asthma monitoring devices, smart inhalers, inhalers, dry powdered inhalers (DPI's), metered dose inhalers (MDI's) and nebulizers. Based on end use, the market is segmented into hospitals, clinics, home use and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Intelligent Asthma Monitoring Devices Market

The global market for intelligent asthma monitoring devices is experiencing significant growth, primarily driven by the rising prevalence of asthma and the growing adoption of smart inhalers. Increasing levels of pollution worldwide contribute to a higher incidence of asthma, thereby driving demand for these advanced monitoring solutions. According to the Centers for Disease Control and Prevention (CDC), over 27 million people in the U.S. are affected by asthma, with a notable prevalence among children. Asthma UK's estimates suggest there are over 300 million individuals suffering from this condition, and this figure is projected to exceed 400 million by 2025. The heightened awareness of the benefits of asthma monitoring devices, alongside technological advancements and increased focus from companies on developing smart inhalers-such as dry powder and metered dose inhalers-are essential factors fueling market growth. Key industry players are leveraging these innovations to improve asthma management and enhance the efficacy of prescribed treatments.

Restraints in the Global Intelligent Asthma Monitoring Devices Market

The Global Intelligent Asthma Monitoring Devices market faces significant restraints, particularly stemming from a lack of awareness regarding the effective utilization of smart inhalers and nebulizers. As pollution levels continue to rise globally, the incidence of asthma cases escalates, highlighting the urgent need for innovative and affordable monitoring devices that empower patients to actively engage in self-monitoring practices. However, the prevailing ignorance about how to properly use these advanced devices limits their adoption and effectiveness, ultimately hindering the overall growth of the intelligent asthma monitoring market. Addressing this knowledge gap is crucial for enhancing patient outcomes and market expansion.

Market Trends of the Global Intelligent Asthma Monitoring Devices Market

The Global Intelligent Asthma Monitoring Devices market is witnessing a significant upward trend, driven by the rising prevalence of asthma and respiratory conditions. Wearable technologies like the ADAMM smart patch exemplify this innovation, offering real-time monitoring of vital symptoms such as cough, respiration rate, and wheezing. These devices not only alert users with vibrations upon detecting deviations from individual norms but also enhance patient safety by sending notifications to caregivers. As healthcare increasingly adopts digital solutions for chronic disease management, the demand for such intelligent monitoring devices is expected to surge, heralding a transformative era in asthma care and patient autonomy.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement
• Trade Analysis

Global Intelligent Asthma Monitoring Devices Market Size by Product & CAGR (2025-2032)

• Market Overview
• Wearable Asthma Monitoring Devices
• Smart Inhalers
• Inhalers
• Dry Powdered Inhalers (DPI's)
• Metered Dose Inhalers (MDI's)
• Nebulizers

Global Intelligent Asthma Monitoring Devices Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Clinics
• Home Use
• Others

Global Intelligent Asthma Monitoring Devices Market Size & CAGR (2025-2032)

• North America (Product, End Use)
  • US
  • Canada
• Europe (Product, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Adherium Limited (New Zealand)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim International GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cohero Health, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Health Care Originals, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vectura Group plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Volansys Technologies Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 3M (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AEvice Health (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Respiri Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quvium (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Findair (Poland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sensirion AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thorasys Thoracic Medical Systems Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vitalograph Ltd. (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zephyr Sleep Technologies (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations